Nanomedicine & Bioconjugation Symposium 2026
Ardena’s first nanomedicine symposium brings together leading scientists, clinicians, and industry experts to discuss the latest advances in nanomedicine. Over two days, you will hear from and engage directly with – international key opinion leaders, industry innovators, and Ardena’s own nanomedicine experts
WHERE
Location
Dome-X, Kanaalstraat 12B. Oss, Netherlands.
WHEN
Date
15–16 September 2026
WHO
Audience
C-level executives, CMC experts, and senior scientists from biotech, pharma, and academia
Speakers
Dr. Glenn Meyer
CMC, Product Development, Peptinovo Biopharma
Prof. Dr. Dr. Twan Lammers
Department of Nanomedicine and Theranostics Institute for Experimental Molecular Imaging RWTH Aachen University Clinic
Agenda
Nanomedicine & Bioconjugation Symposium
15–16 September 2026 · Oss, NL
Registration and Coffee Reception
Session 1: Nanomedicines in clinic
Opening Welcome
Dr. Christian Schröter – Topas Therapeutics
How Nano Helps Patients with Autoimmune Diseases (working title)
Dr. Morten Petersen – MonTa Biosciences
From Bench to Bedside: The Development of MBS8 (1V270), an LNP-based Therapeutic
Coffee break
Prof. Maria Jose Alonso
Designing the Carrier for the Cargo: Rational Engineering of Nanoformulations for Complex Therapeutics
Speaker Q&A and Panel Discussion (Session 1)
Coffee break
Dr. Zdravka Medarova – TransCode Therapeutics
Closing Remarks
Networking Reception
Conference Dinner
Registration and Coffee Reception
Session 2: Next generation drug delivery systems
Prof. Dr. Twan Lammers – RWTH
Strategies to Promote Cancer Nanomedicine Performance and Clinical Translation
Dr. Glenn Meyer – Peptinovo Biopharma
Creation and Characterization of a Novel HDL Like Nanoparticle Delivery System
Cofee Break
Dr. Sander van Berkel (independent) – ADCs
Antibody-drug-conjugates (ADCs) – where small molecules meet big molecules
Dr. Bastiaan Buddingh’ – Ardena
From Formulation to Clinic: A QbD Approach to Scalable Nanomedicine Development
Speaker Q&A and Panel Discussion (Session 2)
Lunch Reception
Session 3: Advanced characterization of nanomedicines
Jeroen Vrancken – Wyatt Technology / Waters
Critical quality attributes of LNP and viruses for gene delivery
Dr. Maria Marioli on analytics – Ardena
Phase-appropriate analytical strategies for nanomedicines: From conventional assays to in-depth characterization
Rivca Valk – Ardena
Challenges in nanomedicine analysis: A bioanalytical case study
Closing Remarks
Guided Site Tour
Guided Tours of Ardena Facilities:
Nanomedicines Facility (KA)
Pilot Plant (RG)
Scientific focus areas
Nanomedicines in clinical development
Bioconjugation
mRNA / LNP formulation strategies
Analytical characterisation of complex modalities
What's included for participants
Selected participants receive
Apply via form below-
Full two-day symposium access
-
Certificate of attendance
-
Networking dinner and welcome reception
-
Guided tour of Ardena’s specialized nanomedicine facility.
Apply to Attend
Places are limited and participants are selected based on scientific background and relevance to the symposium topics.
Selective attendance. Submitting this form is an application, not a confirmed registration. Our team reviews each submission and will contact you within a few working days to confirm your place.
